Search results
Results from the WOW.Com Content Network
It is unclear if phytoestrogens have any effect on the cause or prevention of cancer in women. [ 1 ] [ 36 ] Some epidemiological studies have suggested a protective effect against breast cancer. [ 1 ] [ 36 ] [ 37 ] Additionally, other epidemiological studies found that consumption of soy estrogens is safe for patients with breast cancer, and ...
The results of various studies regarding the use of phytoestrogens in treating breast cancer have been somewhat contradictory and ambiguous, and as a result, researchers cannot clearly define phytoestrogens like coumestrol as being chemoprotective agents or potentially having negative effects, such as inducing further growth of existing breast ...
Phytoestrogens are chemicals which act like the hormone estrogen. Estrogen is important for women's bone and heart health, but high amounts of it has been linked to breast cancer. [18] In the plant, the phytoestrogens are involved in the defense system against fungi. [19] Phytoestrogens can do two different things in a human body.
The study found such chemicals as benzene, a known carcinogen connected to breast cancers in animals and people; 4,4’-Methylenebis-(2-Chloroaniline), a probable carcinogen linked to bladder ...
Genistein was found to increase the rate of proliferation of estrogen-dependent breast cancer when not cotreated with an estrogen antagonist. [51] [52] [53] It was also found to decrease efficiency of tamoxifen and letrozole - drugs commonly used in breast cancer therapy.
Miroestrol is a phytoestrogen, a plant-derived chemical that mimics the biological activity of the hormone estrogen.Miroestrol was first reportedly isolated from the Thai herb Pueraria mirifica in 1960 and thought to be responsible for the supposed rejuvenating properties of the plant. [1]
8-Prenylnaringenin (8-PN; also known as flavaprenin, (S)-8-dimethylallylnaringenin, hopein, or sophoraflavanone B) is a prenylflavonoid phytoestrogen. It is reported to be the most estrogenic phytoestrogen known. [1] The compound is equipotent at the two forms of estrogen receptors, ERα and ERβ, [2] and it acts as a full agonist of ERα. [3]
IUD use linked to 14 breast cancer cases per every 10,000 women. Study participants were followed from the year they started until December 2022, equaling an average of 6.8 years. During that time ...